Pharma: Page 69
-
Biopharma jobs boom in Massachusetts, though challenges still exist
Many more jobs have opened up in R&D than in manufacturing, which saw growth of just 1% between 2017 and 2018.
By Jacob Bell • Aug. 27, 2019 -
Oklahoma judge orders J&J pay $572M in landmark opioid case
At issue was J&J's marketing of opioids Duragesic and Nucynta, as well as its supplying of API to other manufacturers via subsidiaries Noramco and Tasmanian Alkaloids.
By Ned Pagliarulo • Aug. 26, 2019 -
Explore the Trendline➔
National Institute on Aging. (2017). "Beta-Amyloid Plaques and Tau in the Brain" [Image]. Retrieved from Flickr.
TrendlineAlzheimer's disease
Many companies hope to follow in the footsteps of Biogen, Eisai and Eli Lilly by developing new therapies for the debilitating disease, which affects tens of millions of people and costs healthcare systems hundreds of billions of dollars each year.
By BioPharma Dive staff
Previous
To find more content, use the "Topics" in the menu above.
